Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation.

Muromoto R, Taira N, Ikeda O, Shiga K, Kamitani S, Togi S, Kawakami S, Sekine Y, Nanbo A, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2009 Apr 24;382(1):63-8. doi: 10.1016/j.bbrc.2009.02.127. Epub 2009 Feb 28.

PMID:
19254694
2.

An RNA biding protein, Y14 interacts with and modulates STAT3 activation.

Ohbayashi N, Taira N, Kawakami S, Togi S, Sato N, Ikeda O, Kamitani S, Muromoto R, Sekine Y, Matsuda T.

Biochem Biophys Res Commun. 2008 Aug 1;372(3):475-9. doi: 10.1016/j.bbrc.2008.05.073. Epub 2008 May 27.

PMID:
18503751
3.

Structure of the Y14-Magoh core of the exon junction complex.

Lau CK, Diem MD, Dreyfuss G, Van Duyne GD.

Curr Biol. 2003 May 27;13(11):933-41.

4.

Y14 positively regulates TNF-α-induced NF-κB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein.

Togi S, Shiga K, Muromoto R, Kato M, Souma Y, Sekine Y, Kon S, Oritani K, Matsuda T.

J Immunol. 2013 Aug 1;191(3):1436-44. doi: 10.4049/jimmunol.1300501. Epub 2013 Jul 1.

5.

The exon junction core complex is locked onto RNA by inhibition of eIF4AIII ATPase activity.

Ballut L, Marchadier B, Baguet A, Tomasetto C, Séraphin B, Le Hir H.

Nat Struct Mol Biol. 2005 Oct;12(10):861-9. Epub 2005 Sep 18.

PMID:
16170325
6.

HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A.

Togi S, Kamitani S, Kawakami S, Ikeda O, Muromoto R, Nanbo A, Matsuda T.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):616-20. doi: 10.1016/j.bbrc.2008.12.132. Epub 2009 Jan 1.

PMID:
19121623
7.
8.
9.

Association of the breast cancer protein MLN51 with the exon junction complex via its speckle localizer and RNA binding module.

Degot S, Le Hir H, Alpy F, Kedinger V, Stoll I, Wendling C, Seraphin B, Rio MC, Tomasetto C.

J Biol Chem. 2004 Aug 6;279(32):33702-15. Epub 2004 May 27.

10.

Physical and functional interactions between STAT3 and KAP1.

Tsuruma R, Ohbayashi N, Kamitani S, Ikeda O, Sato N, Muromoto R, Sekine Y, Oritani K, Matsuda T.

Oncogene. 2008 May 8;27(21):3054-9. Epub 2007 Nov 26.

PMID:
18037959
11.

Mechanism of ATP turnover inhibition in the EJC.

Nielsen KH, Chamieh H, Andersen CB, Fredslund F, Hamborg K, Le Hir H, Andersen GR.

RNA. 2009 Jan;15(1):67-75. doi: 10.1261/rna.1283109. Epub 2008 Nov 25.

13.

The RNA-binding protein Y14 inhibits mRNA decapping and modulates processing body formation.

Chuang TW, Chang WL, Lee KM, Tarn WY.

Mol Biol Cell. 2013 Jan;24(1):1-13. doi: 10.1091/mbc.E12-03-0217. Epub 2012 Oct 31.

15.

Nuclear protein IkappaB-zeta inhibits the activity of STAT3.

Wu Z, Zhang X, Yang J, Wu G, Zhang Y, Yuan Y, Jin C, Chang Z, Wang J, Yang X, He F.

Biochem Biophys Res Commun. 2009 Sep 18;387(2):348-52. doi: 10.1016/j.bbrc.2009.07.023. Epub 2009 Jul 10.

PMID:
19595668
16.

Y14 and hUpf3b form an NMD-activating complex.

Gehring NH, Neu-Yilik G, Schell T, Hentze MW, Kulozik AE.

Mol Cell. 2003 Apr;11(4):939-49.

17.

Physical and functional interactions between Daxx and STAT3.

Muromoto R, Nakao K, Watanabe T, Sato N, Sekine Y, Sugiyama K, Oritani K, Shimoda K, Matsuda T.

Oncogene. 2006 Mar 30;25(14):2131-6.

PMID:
16331268
18.

hCTR9, a component of Paf1 complex, participates in the transcription of interleukin 6-responsive genes through regulation of STAT3-DNA interactions.

Youn MY, Yoo HS, Kim MJ, Hwang SY, Choi Y, Desiderio SV, Yoo JY.

J Biol Chem. 2007 Nov 30;282(48):34727-34. Epub 2007 Oct 1.

19.

The three-dimensional arcitecture of the EJC core.

Stroupe ME, Tange TØ, Thomas DR, Moore MJ, Grigorieff N.

J Mol Biol. 2006 Jul 21;360(4):743-9. Epub 2006 Jun 5.

PMID:
16797590
20.

Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA.

Andersen CB, Ballut L, Johansen JS, Chamieh H, Nielsen KH, Oliveira CL, Pedersen JS, Séraphin B, Le Hir H, Andersen GR.

Science. 2006 Sep 29;313(5795):1968-72. Epub 2006 Aug 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk